Location of Repository

Glikoznanost - nova smjernica u suvremenom dizajniranju lijekova

By OLGA GORNIK, JERKA DUMIC, MIRNA FLÖGEL and GORDAN LAUC

Abstract

Glycans are the most abundant and most diverse biopolymers in nature. Because of their highly specific interactions with physiological receptors, they participate in many crucial biological processes. All these processes are potential targets for therapeutic intervention, and carbohydrate-based drugs are rapidly being taken up by the modern biotechnology and pharmaceutical industry. Recent developments in the field of glycobiology have overcome the problem of glycan analysis and synthesis; and many compounds based on carbohydrates are now in various stages of clinical trials. This article presents glycoproteins in a new light, as an important biopharmaceutical target, giving an overview of their potential use as therapeutic glycoproteins and proteoglycans, inflammation blockers, cancer therapeutics and vaccines, inhibitors of pathogenic microbes, viral inhibitors and potential aids in the treatment of lysosomal diseases, neurological diseases and transplantation rejection.Glikani su najrasprostranjeniji i najraznolikiji biopolimeri prisutni u prirodi. Zbog svojih interakcija s fiziološkim receptorima sudjeluju u mnogim ključnim biološkim procesima. Svi ti procesi potencijalna su meta terapeutskih intervencija pa lijekovi bazirani na ugljikohidratima nalaze svoje mjesto u suvremenoj biotehnologiji i farmaceutskoj industriji. Razvojem glikobiologije prevladan je problem sinteze i analize glikana pa su mnogi spojevi bazirani na ugljikohidratnim strukturama trenutno u različitim fazama kliničkih ispitivanja. Ovaj članak predstavlja glikoproteine u novom svjetlu, kao važne biofarmaceutske ciljeve, dajući pregled njihove potencijalne primjene kao terapijskih glikoproteina i proteoglikana, inhibitora upale, lijekova i vakcina u liječenju tumora, inhibitora patogenih mikroorganizama i virusa, te potencijalnih sredstava u liječenju lizosomskih i neuroloških bolesti te transplantacijskih reakcija

Topics: glycoproteins; lectins; therapeutics, glikoproteini; lektini; terapeutici
Publisher: Croatian Pharmaceutical Society
Year: 2006
OAI identifier: oai:hrcak.srce.hr:4562

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.